strontium has been researched along with Prostatic Neoplasms, Castration-Resistant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloemendal, HJ; de Klerk, JM; Hoekstra, OS; Hooft, L; Jong, JM; Oprea-Lager, DE; van den Eertwegh, AJ; Verheul, HM | 1 |
| Andronis, L; Barton, D; Beesley, S; Billingham, LJ; Birtle, A; Brown, JE; Chakraborti, P; Collins, S; Daunton, A; Goranitis, I; Hussain, SA; James, ND; McLaren, D; O'Sullivan, JM; Parker, C; Pirrie, S; Pope, A; Porfiri, E; Russell, JM; Staffurth, J; Stanley, A; Wylie, J | 1 |
1 review(s) available for strontium and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Topics: Antineoplastic Agents; Bone Neoplasms; Cancer Pain; Etidronic Acid; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radium; Randomized Controlled Trials as Topic; Strontium; Strontium Radioisotopes | 2016 |
1 trial(s) available for strontium and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Diphosphonates; Disease-Free Survival; Humans; Imidazoles; Male; Prospective Studies; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radiopharmaceuticals; Strontium; United Kingdom; Zoledronic Acid | 2017 |